A smart duo for your insulin management.
Dexcom G7 is the first and only CGM system connected to Tandem Mobi, the smallest durable AID system1-2 in the world, offering more discretion and convenience than ever.*,3
Meet your new insulin management team
Dexcom G7 and Tandem Mobi work together, offering a connected experience for managing diabetes.
Discreet insulin delivery
The impressively small Dexcom G74 and the world's smallest durable AID system1-2 seamlessly connect2 to help reduce interruptions to your daily routine.*
Predict and prevent
Tandem Mobi’s Control-IQ+ technology and Dexcom G7’s exceptional accuracy5-6 can help you spend more time in range.†,7
Superior convenience
With up to 3 wear locations for Dexcom G74 and 18 placements for Tandem Mobi,1-3 you can choose the placement that suits your lifestyle.
Simple from the start
Tandem Mobi and Dexcom G7 offer a seamless connection for a smooth transition to insulin pumps. Over 8 out of 10 users8 found connecting to Dexcom G7 with Tandem Mobi easy. Plus, most users say this integrated system reduced the burden of diabetes management and helped them stay on top of their diabetes.‡,9
Leave your phone. Stay in control.
When you pair Dexcom G7 and Tandem Mobi, you can see your CGM readings on your Apple Watch® and dose bolus insulin from your Mobi pump.§ That means you can leave your phone behind and stay connected.
How they work together
1. Dexcom G7’s accurate sensing lets Tandem Mobi know when your glucose is trending high or low.
2. Tandem Mobi’s Control-IQ+ technology can adjust insulin delivery every 5 minutes and deliver an AutoBolus when your predicted glucose is high.
3. Together you can achieve glycaemic goals of time in range and glucose management indicator (GMI)|| regardless of prior therapy.9
Meet the Dexcom CGM Systems
With Dexcom CGM Systems*, you have the option to choose the insulin pump that works best for you. Glucose readings are sent to your smartphone† – without finger pricks** and no scanning ever. Via an algorithm, this data communicates with your insulin pump to create a hybrid closed loop system for more convenient insulin delivery.
** Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Customer support
NHS funded patient enquiries – [email protected]
Self-funded customer enquiries – [email protected]
New Customer Enquiries - [email protected]
Product support
For product troubleshooting, replacement, or compatibility enquiries, please complete a Product Support Request.
Upgrade Today
Now’s the time to take control of your diabetes with Dexcom G7 and Tandem Mobi.
References:
*Compared to major CGM brands and embedded AID systems as of October 2025.
† Results obtained with a previous generation Tandem insulin pump-Tandem t:Slim x2 and Dexcom G6 and are applicable to Tandem Mobi pump and Dexcom G7 given similar feature sets, performance, and usability.
‡ A total of 394 users answered the questions on psychosocial effects of the system.
§ Precaution: Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters of the Dexcom G7. Always pair the Dexcom G7 sensor with your Tandem system before pairing with the Dexcom G7 app and Apple Watch. The Tandem system communicates directly with the Dexcom G7 sensor to get CGM readings, and does not communicate with the Dexcom G7 app or Apple Watch. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
|| Real world analysis of 1,280 users throughout a 6-week utilization period.
1 Data on File, 2025.
2 Tandem Mobi User Guide, 2023.
3 Habif S, et al. Diabetes. 2024;73(S1):973-P.
4 Dexcom G7 User Guide, 2024.
5 Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-380.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
8 Dexcom survey among T1/T2 AID users based in US. 2025. n=113. Data on File.
9 Akturk, et al. J Diabetes Sci Technol. 2025;19(2):582-583.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. MAT-13674
*Compared to major CGM brands and embedded AID systems as of October 2025.
† Results obtained with a previous generation Tandem insulin pump-Tandem t:Slim x2 and Dexcom G6 and are applicable to Tandem Mobi pump and Dexcom G7 given similar feature sets, performance, and usability.
‡ A total of 394 users answered the questions on psychosocial effects of the system.
§ Precaution: Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters of the Dexcom G7. Always pair the Dexcom G7 sensor with your Tandem system before pairing with the Dexcom G7 app and Apple Watch. The Tandem system communicates directly with the Dexcom G7 sensor to get CGM readings, and does not communicate with the Dexcom G7 app or Apple Watch. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
|| Real world analysis of 1,280 users throughout a 6-week utilization period.
1 Data on File, 2025.
2 Tandem Mobi User Guide, 2023.
3 Habif S, et al. Diabetes. 2024;73(S1):973-P.
4 Dexcom G7 User Guide, 2024.
5 Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-380.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
8 Dexcom survey among T1/T2 AID users based in US. 2025. n=113. Data on File.
9 Akturk, et al. J Diabetes Sci Technol. 2025;19(2):582-583.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. MAT-13674